| Symbol | BTMD |
|---|---|
| Name | BIOTE CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | 1875 W. WALNUT HILL LN,SUITE 100, IRVING, Texas, 75038, United States |
| Telephone | 972-486-9346 |
| Fax | — |
| — | |
| Website | https://www.biote.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. Additional info from NASDAQ: |
New Form S-8 - biote Corp. <b>Filed:</b> 2026-04-14 <b>AccNo:</b> 0001193125-26-155037 <b>Size:</b> 288 KB
Read moreChristensen Bret 🟢 acquired 441.7K shares (1 derivative) of biote Corp. (BTMD) at $1.43 Transaction Date: Apr 01, 2026 | Filing ID: 000002
Read morePeterson Robert Charles 🟢 acquired 107.2K shares (1 derivative) of biote Corp. (BTMD) at $1.43 Transaction Date: Apr 01, 2026 | Filing ID: 000002
Read moreNew Form ARS - biote Corp. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-140116 <b>Size:</b> 17 MB
Read moreNew Form DEFA14A - biote Corp. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-140105 <b>Size:</b> 101 KB
Read moreNew Form DEF 14A - biote Corp. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-140096 <b>Size:</b> 2 MB
Read moreBiote Schedules Third Quarter 2025 Financial Results Release and Conference Call
Read more